trial

Brain Stimulation to the Hippocampus in Schizophrenia

NCTId NCT07010614
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 60 (estimated)
Sponsored by Stanford University
Primary completion 2027-09-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Single
Start
2025-10-01
Primary completion
2027-09-30
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Intracranial electrodesTMS

Sponsors

Stanford UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Ethan A Solomon, MD, PhDPrincipal Investigator

Sites

1 total
Stanford, United States

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2027-09-30
Status
RECRUITING
relationships
The graph out of here
drug
Intracranial electrodes
drug
TMS
drug
lead_sponsor
Stanford University
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Mental Disorder
indication
Psychotic Disorders
indication
Schizophrenia Disorders
indication
investigator
Ethan A Solomon, MD, PhD
person